Total Payments
$42,026
2024 Payments
$1,708
Companies
46
Transactions
457
Medicare Patients
3,431
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$13,965 (33.2%)
Other$13,317 (31.7%)
Consulting$8,330 (19.8%)
Travel$5,942 (14.1%)
Education$472.65 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,965 | 407 | 33.2% |
| Consulting Fee | $8,330 | 2 | 19.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,920 | 5 | 18.8% |
| Travel and Lodging | $5,942 | 20 | 14.1% |
| Honoraria | $5,230 | 6 | 12.4% |
| Education | $472.65 | 15 | 1.1% |
| Entertainment | $166.60 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $8,257 | 25 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $6,031 | 20 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $5,371 | 32 | $0 (2024) |
| Astute Medical, Inc. | $4,189 | 13 | $0 (2018) |
| CALLIDITAS THERAPEUTICS US INC. | $2,512 | 8 | $0 (2024) |
| Grifols Biologicals LLC | $2,490 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,852 | 42 | $0 (2024) |
| Baxter Healthcare | $1,700 | 1 | $0 (2019) |
| Amgen Inc. | $1,455 | 40 | $0 (2024) |
| Horizon Therapeutics plc | $619.24 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,708 | 25 | AstraZeneca Pharmaceuticals LP ($418.69) |
| 2023 | $11,448 | 34 | Bayer Healthcare Pharmaceuticals Inc. ($7,958) |
| 2022 | $1,562 | 49 | AstraZeneca Pharmaceuticals LP ($317.14) |
| 2021 | $1,338 | 47 | Amgen Inc. ($297.88) |
| 2020 | $548.46 | 20 | AstraZeneca Pharmaceuticals LP ($184.09) |
| 2019 | $11,169 | 84 | Fresenius USA Marketing, Inc. ($5,024) |
| 2018 | $4,798 | 75 | Merck Sharp & Dohme Corporation ($2,535) |
| 2017 | $9,455 | 123 | Astute Medical, Inc. ($3,816) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: CRITICAL CARE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $119.51 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $35.85 | General |
| 10/18/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device), LIBERTY SELECT CYCLER | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: Nephrology | ||||||
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $104.76 | General |
| Category: CRITICAL CARE | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.98 | General |
| 09/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Rare Disease | ||||||
| 08/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $98.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/12/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 06/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $141.33 | General |
| 06/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 04/05/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Nephrology | ||||||
| 03/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $136.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2024 | NXSTAGE MEDICAL, INC. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $87.66 | General |
| Category: Nephrology | ||||||
| 02/29/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: Inflammation | ||||||
| 02/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 02/19/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Education | In-kind items and services | $10.60 | General |
| Category: CRITICAL CARE | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $52.64 | General |
| Category: Nephrology | ||||||
| 01/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $119.00 | General |
| Category: Nephrology | ||||||
| 01/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 01/11/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $44.85 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 791 | 1,820 | $585,043 | $255,087 |
| 2022 | 12 | 843 | 1,957 | $565,926 | $244,019 |
| 2021 | 13 | 885 | 2,063 | $623,751 | $281,248 |
| 2020 | 16 | 912 | 2,212 | $633,265 | $273,182 |
Total Patients
3,431
Total Services
8,052
Medicare Billing
$1.1M
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 57 | 369 | $228,450 | $107,951 | 47.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 56 | 167 | $86,893 | $40,783 | 46.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 149 | 347 | $55,155 | $22,614 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 245 | $58,082 | $19,662 | 33.9% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 69 | $35,708 | $16,867 | 47.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 89 | $37,942 | $12,587 | 33.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 75 | 122 | $27,109 | $11,958 | 44.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 99 | 238 | $20,145 | $9,653 | 47.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 51 | $15,921 | $5,419 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 68 | $11,082 | $4,364 | 39.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 37 | 55 | $8,556 | $3,230 | 37.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 62 | 366 | $223,260 | $111,580 | 50.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 169 | 448 | $71,613 | $26,372 | 36.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 38 | 103 | $52,839 | $26,184 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 253 | $59,455 | $21,160 | 35.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 84 | 225 | $53,553 | $19,137 | 35.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 92 | 99 | $42,720 | $16,266 | 38.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 110 | 283 | $23,863 | $9,004 | 37.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 37 | $10,947 | $4,159 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 62 | $10,044 | $4,015 | 40.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 39 | 48 | $7,488 | $2,904 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,984 | $1,998 | 33.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 16 | 16 | $4,160 | $1,240 | 29.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 62 | 391 | $238,510 | $118,984 | 49.9% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 45 | 111 | $56,943 | $27,542 | 48.4% |
About Dr. John Videen, MD
Dr. John Videen, MD is a Nephrology healthcare provider based in Chula Vista, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043318199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Videen, MD has received a total of $42,026 in payments from pharmaceutical and medical device companies, with $1,708 received in 2024. These payments were reported across 457 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($13,965).
As a Medicare-enrolled provider, Videen has provided services to 3,431 Medicare beneficiaries, totaling 8,052 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Chula Vista, CA
- Active Since 09/20/2006
- Last Updated 01/29/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043318199
Products in Payments
- Kerendia (Drug) $8,227
- ZEPATIER (Drug) $5,994
- Velphoro (Drug) $5,300
- NephroCheck Test (Device) $3,816
- Albutein (Biological) $2,633
- TARPEYO (Drug) $2,512
- Renal - Acute (Device) $1,700
- KRYSTEXXA (Biological) $723.16
- Veltassa (Drug) $638.80
- Parsabiv (Biological) $618.73
- JARDIANCE (Drug) $470.02
- LUPKYNIS (Drug) $463.19
- Parsabiv (Drug) $425.74
- TERLIVAZ (Drug) $405.76
- SAMSCA (Drug) $392.01
- Nephrocheck (Device) $373.67
- FARXIGA (Drug) $358.95
- Rayaldee (Drug) $319.22
- ULTOMIRIS (Biological) $266.63
- LOKELMA (Drug) $248.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chula Vista
Jill Meyer, Md, MD
Nephrology — Payments: $12,736
Nephrology $12,736
Dr. Diogo Belo, M.d, M.D
Nephrology — Payments: $10,080
Nephrology $10,080
Rodrigo Fernandez, Md, MD
Nephrology — Payments: $9,733
Nephrology $9,733
Dr. Ricardo Soltero, M.d, M.D
Nephrology — Payments: $5,174
Nephrology $5,174
Adam Horeish, Md, MD
Nephrology — Payments: $5,107
Nephrology $5,107
Dr. Elizabeth Lozada-Pastorio, M.d, M.D
Nephrology — Payments: $4,736
Nephrology $4,736